FDA approves faster, easier treatment for hepatitis C

FDA approves faster, easier treatment for hepatitis C

Sofosbuvir, which has the brand name Sovaldi, will be the first treatment that some patients will be able to take for just 12 weeks with just one additional drug and no interferon. The FDA approved the no-interferon combination for patients with two

8
Like
Save

Comments

Write a comment

*